Informational Posters - 1
November 06, 2025 | 10:00 AM - 12:00 PM
Click an icon below to load this item into your calendar. Please note that times are exported as Coordinated Universal Time (UTC). Time zone help.
- NEW! Navigating the National Institute of Diabetes and Digestive and Kidney Diseases
10:00 AM - 12:00 PM
NEW! Navigating the National Institute of Diabetes and Digestive and Kidney Diseases
November 06, 2025 | 10:00 AM - 12:00 PM
Click an icon below to load this item into your calendar. Please note that times are exported as Coordinated Universal Time (UTC). Time zone help.
- Resources for Clinical and Epidemiology Research from the National Institute of Diabetes and Digestive and Kidney Diseases
10:00 AM - 12:00 PM
Resources for Clinical and Epidemiology Research from the National Institute of Diabetes and Digestive and Kidney Diseases
November 06, 2025 | 10:00 AM - 12:00 PM
Click an icon below to load this item into your calendar. Please note that times are exported as Coordinated Universal Time (UTC). Time zone help.
- Funding Opportunities from the National Institute of Diabetes and Digestive and Kidney Diseases
10:00 AM - 12:00 PM
Funding Opportunities from the National Institute of Diabetes and Digestive and Kidney Diseases
November 06, 2025 | 10:00 AM - 12:00 PM
Click an icon below to load this item into your calendar. Please note that times are exported as Coordinated Universal Time (UTC). Time zone help.
- Training and Career Development Programs from the National Institute of Diabetes and Digestive and Kidney Diseases
10:00 AM - 12:00 PM
Training and Career Development Programs from the National Institute of Diabetes and Digestive and Kidney Diseases
November 06, 2025 | 10:00 AM - 12:00 PM
Click an icon below to load this item into your calendar. Please note that times are exported as Coordinated Universal Time (UTC). Time zone help.
- Indiana O'Brien Center for Advanced Renal Microscopy and Molecular Imaging
10:00 AM - 12:00 PM
Indiana O'Brien Center for Advanced Renal Microscopy and Molecular Imaging
November 06, 2025 | 10:00 AM - 12:00 PM
Click an icon below to load this item into your calendar. Please note that times are exported as Coordinated Universal Time (UTC). Time zone help.
- Kidney Disease Surveillance System: Tracking and Preventing Kidney Disease in the United States - A Resource for Researchers and Clinicians for Kidney Disease Data
10:00 AM - 12:00 PM
Kidney Disease Surveillance System: Tracking and Preventing Kidney Disease in the United States - A Resource for Researchers and Clinicians for Kidney Disease Data
November 06, 2025 | 10:00 AM - 12:00 PM
Click an icon below to load this item into your calendar. Please note that times are exported as Coordinated Universal Time (UTC). Time zone help.
- Cure Glomerulonephropathy Network (CureGN)
10:00 AM - 12:00 PM
Cure Glomerulonephropathy Network (CureGN)
November 06, 2025 | 10:00 AM - 12:00 PM
Click an icon below to load this item into your calendar. Please note that times are exported as Coordinated Universal Time (UTC). Time zone help.
- NEPTUNE: Nephrotic Syndrome Study Network
10:00 AM - 12:00 PM
NEPTUNE: Nephrotic Syndrome Study Network
November 06, 2025 | 10:00 AM - 12:00 PM
Click an icon below to load this item into your calendar. Please note that times are exported as Coordinated Universal Time (UTC). Time zone help.
- Randomized, Controlled Phase 2 Study to Evaluate Iptacopan Treatment in Patients with Active ANCA-Associated Vasculitis
10:00 AM - 12:00 PM
Randomized, Controlled Phase 2 Study to Evaluate Iptacopan Treatment in Patients with Active ANCA-Associated Vasculitis
November 06, 2025 | 10:00 AM - 12:00 PM
Click an icon below to load this item into your calendar. Please note that times are exported as Coordinated Universal Time (UTC). Time zone help.
- A Randomized, Controlled, Multicenter, Phase 2 Clinical Study Evaluating the Efficacy, Safety, and Tolerability of HLX79 Combined with a Rituximab Biosimilar in Patients with Active Glomerulonephritis
10:00 AM - 12:00 PM
A Randomized, Controlled, Multicenter, Phase 2 Clinical Study Evaluating the Efficacy, Safety, and Tolerability of HLX79 Combined with a Rituximab Biosimilar in Patients with Active Glomerulonephritis
November 06, 2025 | 10:00 AM - 12:00 PM
Click an icon below to load this item into your calendar. Please note that times are exported as Coordinated Universal Time (UTC). Time zone help.
- ACTION3: A Phase 3 Study of DMX-200 for the Treatment of FSGS
10:00 AM - 12:00 PM
ACTION3: A Phase 3 Study of DMX-200 for the Treatment of FSGS
November 06, 2025 | 10:00 AM - 12:00 PM
Click an icon below to load this item into your calendar. Please note that times are exported as Coordinated Universal Time (UTC). Time zone help.
- ORIGIN Extend: A Long-Term Extension Study of Atacicept in IgAN
10:00 AM - 12:00 PM
ORIGIN Extend: A Long-Term Extension Study of Atacicept in IgAN
November 06, 2025 | 10:00 AM - 12:00 PM
Click an icon below to load this item into your calendar. Please note that times are exported as Coordinated Universal Time (UTC). Time zone help.
- PIONEER: A Basket Trial of Atacicept in Autoimmune Mediated Glomerular Disease
10:00 AM - 12:00 PM
PIONEER: A Basket Trial of Atacicept in Autoimmune Mediated Glomerular Disease
November 06, 2025 | 10:00 AM - 12:00 PM
Click an icon below to load this item into your calendar. Please note that times are exported as Coordinated Universal Time (UTC). Time zone help.
- Investigating Extended Nefecon Treatment Beyond Nine Months in Patients with IgAN: The Phase 4 NefXtend Trial
10:00 AM - 12:00 PM
Investigating Extended Nefecon Treatment Beyond Nine Months in Patients with IgAN: The Phase 4 NefXtend Trial
November 06, 2025 | 10:00 AM - 12:00 PM
Click an icon below to load this item into your calendar. Please note that times are exported as Coordinated Universal Time (UTC). Time zone help.
- Pegcetacoplan for Adolescents and Adults with C3 Glomerulopathy or Primary Immune-Complex Membranoproliferative Glomerulonephritis: Enrollment Status of the VALE Extension
10:00 AM - 12:00 PM
Pegcetacoplan for Adolescents and Adults with C3 Glomerulopathy or Primary Immune-Complex Membranoproliferative Glomerulonephritis: Enrollment Status of the VALE Extension
November 06, 2025 | 10:00 AM - 12:00 PM
Click an icon below to load this item into your calendar. Please note that times are exported as Coordinated Universal Time (UTC). Time zone help.
- Pegcetacoplan for Adults with High Risk of Delayed Graft Function: A Phase 3, Randomized, Placebo-Controlled Trial
10:00 AM - 12:00 PM
Pegcetacoplan for Adults with High Risk of Delayed Graft Function: A Phase 3, Randomized, Placebo-Controlled Trial
November 06, 2025 | 10:00 AM - 12:00 PM
Click an icon below to load this item into your calendar. Please note that times are exported as Coordinated Universal Time (UTC). Time zone help.
- TRANSCEND: A Phase 3 Trial of the Anti-CD38 Antibody Felzartamab in Kidney Transplant Recipients with Late Antibody-Mediated Rejection
10:00 AM - 12:00 PM
TRANSCEND: A Phase 3 Trial of the Anti-CD38 Antibody Felzartamab in Kidney Transplant Recipients with Late Antibody-Mediated Rejection
November 06, 2025 | 10:00 AM - 12:00 PM
Click an icon below to load this item into your calendar. Please note that times are exported as Coordinated Universal Time (UTC). Time zone help.
- TRANSPIRE: A Phase 2 Trial Evaluating the Efficacy and Safety of Felzartamab in Kidney Transplant Recipients with Late Isolated Microvascular Inflammation
10:00 AM - 12:00 PM
TRANSPIRE: A Phase 2 Trial Evaluating the Efficacy and Safety of Felzartamab in Kidney Transplant Recipients with Late Isolated Microvascular Inflammation
November 06, 2025 | 10:00 AM - 12:00 PM
Click an icon below to load this item into your calendar. Please note that times are exported as Coordinated Universal Time (UTC). Time zone help.
- Phase 3 Study of AND017, a Hypoxia-Inducible Factor-Prolyl Hydroxylase Inhibitor (HIF-PHI), in Anemic Patients with Dialysis-Dependent CKD (DD-CKD)
10:00 AM - 12:00 PM
Phase 3 Study of AND017, a Hypoxia-Inducible Factor-Prolyl Hydroxylase Inhibitor (HIF-PHI), in Anemic Patients with Dialysis-Dependent CKD (DD-CKD)
November 06, 2025 | 10:00 AM - 12:00 PM
Click an icon below to load this item into your calendar. Please note that times are exported as Coordinated Universal Time (UTC). Time zone help.
- Phase 3 Study of AND017, a Hypoxia-Inducible Factor-Prolyl Hydroxylase Inhibitor (HIF-PHI), in Patients with Anemia Due to Nondialysis-Dependent CKD (NDD-CKD)
10:00 AM - 12:00 PM
Phase 3 Study of AND017, a Hypoxia-Inducible Factor-Prolyl Hydroxylase Inhibitor (HIF-PHI), in Patients with Anemia Due to Nondialysis-Dependent CKD (NDD-CKD)
November 06, 2025 | 10:00 AM - 12:00 PM
Click an icon below to load this item into your calendar. Please note that times are exported as Coordinated Universal Time (UTC). Time zone help.
